Impact of a national helminth control programme on infection and morbidity in Ugandan schoolchildren

scientific article

Impact of a national helminth control programme on infection and morbidity in Ugandan schoolchildren is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2471/BLT.06.030353
P932PMC publication ID2174620
P698PubMed publication ID17308729

P50authorAlan FenwickQ50307321
Russell StothardQ55303062
Simon BrookerQ56762824
Narcis B KabatereineQ56762863
Edridah M TukahebwaQ56762882
Artemis KoukounariQ59988709
Joanne P. WebsterQ67877771
P2093author name stringYaobi Zhang
Francis Kazibwe
Fiona M Fleming
P2860cites workControl of Schistosoma mansoni and intestinal helminths: 8-year follow-up of an urban school programme in Bujumbura, BurundiQ39387669
Hemoquant determination of hookworm-related blood loss and its role in iron deficiency in African childrenQ39492306
A community-based randomized trial of praziquantel to control schistosomiasis morbidity in schoolchildren in ZambiaQ39497041
Reversibility of Schistosoma mansoni-associated morbidity after yearly mass praziquantel therapy: ultrasonographic assessment.Q41484277
Hookworm control as a strategy to prevent iron deficiencyQ41582192
Parasitic infections, anaemia and nutritional status: a study of their interrelationships and the effect of prophylaxis and treatment on workers in Kwale District, KenyaQ41921906
Schistosomiasis and soil-transmitted helminth infections: forging control effortsQ42147194
The impact of a school health programme on the prevalence and morbidity of urinary schistosomiasis in Mwera Division, Pangani District, TanzaniaQ43342666
Community perception of school-based delivery of anthelmintics in Ghana and TanzaniaQ43414547
Comparison of different chemotherapy strategies against Schistosoma mansoni in Machakos District, Kenya: effects on human infection and morbidityQ43904275
New initiatives against Africa's wormsQ44641296
Regression of hepatosplenomegaly in Kenyan school-aged children after praziquantel treatment and three years of greatly reduced exposure to Schistosoma mansoniQ45192925
A field trial using praziquantel (BiltricideR) to treat Schistosoma mansoni and Schistosoma haematobium infection in Gezira, SudanQ46475815
Relationships of Schistosoma hematobium, hookworm and malarial infections and metrifonate treatment to hemoglobin level in Kenyan school childrenQ46534525
Anaemia caused by asymptomatic plasmodium falciparum infection in semi-immune african schoolchildrenQ47861826
Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: reversibility of morbidity twenty-three months after treatment with praziquantelQ68109476
Dynamic models of schistosomiasis morbidityQ71244456
Better health, nutrition and education for the school-aged child. The Partnership for Child DevelopmentQ73203487
The health and nutritional status of schoolchildren in Africa: evidence from school-based health programmes in Ghana and Tanzania. The Partnership for Child DevelopmentQ77711851
The cost of large-scale school health programmes which deliver anthelmintics to children in Ghana and Tanzania. The Partnership for Child DevelopmentQ78180275
Evaluation of efficacy of school-based anthelmintic treatments against anaemia in children in the United Republic of TanzaniaQ28350276
Planning chemotherapy based schistosomiasis control: validation of a mathematical model using data on Schistosoma haematobium from Pemba, TanzaniaQ33179863
Evaluation designs for adequacy, plausibility and probability of public health programme performance and impactQ33589623
Design and analysis issues in cluster-randomized trials of interventions against infectious diseasesQ34006485
The impact of chemotherapy on morbidity due to schistosomiasisQ35126805
Drugs for the control of parasitic diseases: current status and development in schistosomiasisQ35569078
Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and controlQ35680581
Evaluating the epidemiological impact of national control programmes for helminthsQ35912008
Spatial analysis of the distribution of intestinal nematode infections in UgandaQ35989165
Human schistosomiasis and anemia: the relationship and potential mechanismsQ36169020
Conquering schistosomiasis in China: the long marchQ36324372
The development of an age structured model for schistosomiasis transmission dynamics and control and its validation forSchistosoma mansoniQ36503901
Progress towards countrywide control of schistosomiasis and soil-transmitted helminthiasis in UgandaQ38454931
Morbidity indicators of Schistosoma mansoni: relationship between infection and anemia in Ugandan schoolchildren before and after praziquantel and albendazole chemotherapy.Q38879183
Efficacy and side effects of praziquantel treatment in a highly endemic Schistosoma mansoni focus at Lake Albert, UgandaQ38881798
Epidemiology and geography of Schistosoma mansoni in Uganda: implications for planning controlQ38882358
Hepatosplenic morbidity in two neighbouring communities in Uganda with high levels of Schistosoma mansoni infection but very different durations of residenceQ38882377
Evidence for a long-term effect of a single dose of praziquantel on Schistosoma mansoni-induced hepatosplenic lesions in northern UgandaQ38886669
Epidemiological and control aspects of schistosomiasis in Brazilian endemic areas.Q38954750
Issues in the design and interpretation of studies to evaluate the impact of community-based interventionsQ39138986
Efficacy and side effects of praziquantel against Schistosoma mansoni in a community of western Côte d'IvoireQ39385067
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectUgandaQ1036
P1104number of pages9
P5008on focus list of Wikimedia projectScienceSourceQ55439927
P304page(s)91-99
P577publication date2007-02-01
P1433published inBulletin of the World Health OrganizationQ2928049
P1476titleImpact of a national helminth control programme on infection and morbidity in Ugandan schoolchildren
P478volume85

Reverse relations

cites work (P2860)
Q92510183A Search for Snail-Related Answers to Explain Differences in Response of Schistosoma mansoni to Praziquantel Treatment among Responding and Persistent Hotspot Villages along the Kenyan Shore of Lake Victoria
Q38854033A centenary of Robert T. Leiper's lasting legacy on schistosomiasis and a COUNTDOWN on control of neglected tropical diseases
Q35075083A latent Markov modelling approach to the evaluation of circulating cathodic antigen strips for schistosomiasis diagnosis pre- and post-praziquantel treatment in Uganda
Q21562256A research agenda for helminth diseases of humans: Intervention for control and elimination
Q21144498A research agenda for helminth diseases of humans: The problem of helminthiases
Q21562257A research agenda for helminth diseases of humans: Towards control and elimination
Q28539669A school-based cross-sectional survey of adverse events following co-administration of albendazole and praziquantel for preventive chemotherapy against urogenital schistosomiasis and soil-transmitted helminthiasis in Kwale County, Kenya
Q39142089A single FLOTAC is more sensitive than triplicate Kato-Katz for the diagnosis of low-intensity soil-transmitted helminth infections
Q28534849A very high infection intensity of Schistosoma mansoni in a Ugandan Lake Victoria Fishing Community is required for association with highly prevalent organ related morbidity
Q52610773Albendazole Treatment Improves Work Capacity in Women Smallholder Farmers Infected with Hookworm: A Double-Blind Randomized Control Trial.
Q39409682An audacious goal: the elimination of schistosomiasis in our lifetime through mass drug administration
Q38852112An extensive burden of giardiasis associated with intestinal schistosomiasis and anaemia in school children on the shoreline of Lake Albert, Uganda
Q28752190An updated atlas of human helminth infections: the example of East Africa
Q38869597Anaemia in Ugandan preschool-aged children: the relative contribution of intestinal parasites and malaria
Q33294065Anaemia: a useful indicator of neglected disease burden and control
Q28475501Analysis of complex patterns of human exposure and immunity to Schistosomiasis mansoni: the influence of age, sex, ethnicity and IgE
Q62486477Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity
Q38660139Change in children's school behavior after mass administration of praziquantel for Schistosoma mansoni infection in endemic areas of western Kenya: A pilot study using the Behavioral Assessment System for Children (BASC-2).
Q34001292Closing the praziquantel treatment gap: new steps in epidemiological monitoring and control of schistosomiasis in African infants and preschool-aged children
Q35016101Community perceptions, attitude, practices and treatment seeking behaviour for schistosomiasis in L. Victoria islands in Uganda
Q34629346Comparing parasitological vs serological determination of Schistosoma haematobium infection prevalence in preschool and primary school-aged children: implications for control programmes
Q33833108Confirmed local endemicity and putative high transmission of Schistosoma mansoni in the Sesse Islands, Lake Victoria, Uganda
Q34331536Control of neglected tropical diseases needs a long-term commitment
Q37087378Cost and cost-effectiveness of nationwide school-based helminth control in Uganda: intra-country variation and effects of scaling-up
Q35805295De-politicizing parasites: reflections on attempts to control the control of neglected tropical diseases
Q36284173Decline in infection-related morbidities following drug-mediated reductions in the intensity of Schistosoma infection: A systematic review and meta-analysis
Q43924383Defining Persistent Hotspots: Areas That Fail to Decrease Meaningfully in Prevalence after Multiple Years of Mass Drug Administration with Praziquantel for Control of Schistosomiasis.
Q44072486Defining the Necessary Next Steps for Effective Control of Helminthic Infections
Q37330975Development and evaluation of a Markov model to predict changes in schistosomiasis prevalence in response to praziquantel treatment: a case study of Schistosoma mansoni in Uganda and Mali
Q37026044Deworming the world
Q51144224Diet and hygiene practices influence morbidity in schoolchildren living in Schistosomiasis endemic areas along Lake Victoria in Kenya and Tanzania-A cross-sectional study
Q34510642Does mass drug administration for the integrated treatment of neglected tropical diseases really work? Assessing evidence for the control of schistosomiasis and soil-transmitted helminths in Uganda
Q36803942Effect of chemotherapy with praziquantel on the production of cytokines and morbidity associated with schistosomiasis mansoni.
Q36506153Effects of treatment on IgE responses against parasite allergen-like proteins and immunity to reinfection in childhood schistosome and hookworm coinfections
Q42906063Efficient multicomponent reaction synthesis of the schistosomiasis drug praziquantel.
Q36204615Estimation of changes in the force of infection for intestinal and urogenital schistosomiasis in countries with schistosomiasis control initiative-assisted programmes
Q39583417Evaluation and application of potential schistosome-associated morbidity markers within large-scale mass chemotherapy programmes.
Q33847447Evaluation of mammalian and intermediate host surveillance methods for detecting schistosomiasis reemergence in southwest China.
Q28476200Geographical distribution of intestinal schistosomiasis and soil-transmitted helminthiasis and preventive chemotherapy strategies in Sierra Leone
Q60932194Health, financial, and education gains of investing in preventive chemotherapy for schistosomiasis, soil-transmitted helminthiases, and lymphatic filariasis in Madagascar: A modeling study
Q34571264Heterogeneities and consequences of Plasmodium species and hookworm coinfection: a population based study in Uganda
Q84507812High levels of Schistosoma mansoni infections among schoolchildren in central Sudan one year after treatment with praziquantel
Q39002259Host-parasite relations and implications for control
Q50532009Impact of Four Years of Annual Mass Drug Administration on Prevalence and Intensity of Schistosomiasis among Primary and High School Children in Western Kenya: A Repeated Cross-Sectional Study
Q37037295Impact of two rounds of praziquantel mass drug administration on Schistosoma mansoni infection prevalence and intensity: a comparison between community wide treatment and school based treatment in western Kenya
Q34341901In vitro praziquantel test capable of detecting reduced in vivo efficacy in Schistosoma mansoni human infections
Q35065331Increasing teacher motivation and supervision is an important but not sufficient strategy for improving praziquantel uptake in Schistosoma mansoni control programs: serial cross sectional surveys in Uganda
Q35825988Influence of Schistosoma mansoni and Hookworm Infection Intensities on Anaemia in Ugandan Villages
Q35721392Integrated prevalence mapping of schistosomiasis, soil-transmitted helminthiasis and malaria in lakeside and island communities in Lake Victoria, Uganda
Q36248914Intestinal helminth infections and nutritional status of children attending primary schools in Wakiso District, Central Uganda
Q37625862Intestinal schistosomiasis in Uganda at high altitude (>1400 m): malacological and epidemiological surveys on Mount Elgon and in Fort Portal crater lakes reveal extra preventive chemotherapy needs
Q58643310Lessons from the first clinical trial of a non-licensed vaccine among Ugandan adolescents: a phase II field trial of the tuberculosis candidate vaccine, MVA85A
Q57296452Low Praziquantel Treatment Coverage for in Mayuge District, Uganda, Due to the Absence of Treatment Opportunities, Rather Than Systematic Non-Compliance
Q38877241Malaria and hookworm infections in relation to haemoglobin and serum ferritin levels in pregnancy in Masindi district, western Uganda
Q28607740Malaria, anaemia and under-nutrition: three frequently co-existing conditions among preschool children in rural Rwanda
Q34134448Mass drug administration significantly reduces infection of Schistosoma mansoni and hookworm in school children in the national control program in Sierra Leone
Q38895404Modeling the economic and epidemiologic impact of hookworm vaccine and mass drug administration (MDA) in Brazil, a high transmission setting
Q33486177Molecular epidemiology of Schistosoma mansoni in Uganda: DNA barcoding reveals substantial genetic diversity within Lake Albert and Lake Victoria populations.
Q64095900Non-invasive surveillance of Plasmodium infection by real-time PCR analysis of ethanol preserved faeces from Ugandan school children with intestinal schistosomiasis
Q28476209Observed reductions in Schistosoma mansoni transmission from large-scale administration of praziquantel in Uganda: a mathematical modelling study
Q38927082One hundred years of neglect in paediatric schistosomiasis
Q33296532Parasitological impact of 2-year preventive chemotherapy on schistosomiasis and soil-transmitted helminthiasis in Uganda.
Q21562254Partnering parasites: evidence of synergism between heavy Schistosoma haematobium and Plasmodium species infections in Kenyan children
Q91735806Persistent Hotspots in Schistosomiasis Consortium for Operational Research and Evaluation Studies for Gaining and Sustaining Control of Schistosomiasis after Four Years of Mass Drug Administration of Praziquantel
Q36195856Plasmodium infection, anaemia and mosquito net use among school children across different settings in Kenya
Q33503219Polyparasite helminth infections and their association to anaemia and undernutrition in Northern Rwanda
Q33805145Praziquantel decreases fecundity in Schistosoma mansoni adult worms that survive treatment: evidence from a laboratory life-history trade-offs selection study.
Q64089349Prevalence and clinical outcomes of Plasmodium falciparum and intestinal parasitic infections among children in Kiryandongo refugee camp, mid-Western Uganda: a cross sectional study
Q33869191Prevalence of Anaemia and Associated Risk Factors among Children in North-western Uganda: A Cross Sectional Study
Q36256196Prevalence of Schistosomes and Soil-Transmitted Helminths among Schoolchildren in Lake Victoria Basin, Tanzania
Q56910300Prevalence, intensity and factors associated with soil-transmitted helminths infections among preschool-age children in Hoima district, rural western Uganda
Q38873931Process evaluation of schistosomiasis control in Uganda, 2003 to 2006: perceptions, attitudes and constraints of a national programme
Q28485197Projecting the long-term impact of school- or community-based mass-treatment interventions for control of Schistosoma infection
Q37557676Prospects for the control of neglected tropical diseases by mass drug administration
Q35665650Protective Potential of Antioxidant Enzymes as Vaccines for Schistosomiasis in a Non-Human Primate Model.
Q30397196Rapid mapping of schistosomiasis and other neglected tropical diseases in the context of integrated control programmes in Africa.
Q36089146Reduced Efficacy of Praziquantel Against Schistosoma mansoni Is Associated With Multiple Rounds of Mass Drug Administration
Q37461456Remote sensing, geographical information system and spatial analysis for schistosomiasis epidemiology and ecology in Africa
Q60044656Repeated doses of Praziquantel in Schistosomiasis Treatment (RePST) - single versus multiple praziquantel treatments in school-aged children in Côte d'Ivoire: a study protocol for an open-label, randomised controlled trial
Q36209379Schistosoma haematobium infections among schoolchildren in central Sudan one year after treatment with praziquantel
Q33796476Schistosoma mansoni Infections in young children: when are schistosome antigens in urine, eggs in stool and antibodies to eggs first detectable?
Q35856989Schistosoma mansoni among pre-school children in Musozi village, Ukerewe Island, North-Western-Tanzania: prevalence and associated risk factors
Q37493576Schistosoma mansoni infection after three years of mass drug administration in Sierra Leone
Q36450651Schistosoma mansoni morbidity among school-aged children: a SCORE project in Kenya
Q96762042Sensitive diagnostic tools and targeted drug administration strategies are needed to eliminate schistosomiasis
Q28542928Sensitivity and specificity of multiple Kato-Katz thick smears and a circulating cathodic antigen test for Schistosoma mansoni diagnosis pre- and post-repeated-praziquantel treatment
Q28481702Significantly reduced intensity of infection but persistent prevalence of schistosomiasis in a highly endemic region in Mali after repeated treatment
Q28547483Single Versus Double Dose Praziquantel Comparison on Efficacy and Schistosoma mansoni Re-Infection in Preschool-Age Children in Uganda: A Randomized Controlled Trial
Q37310901Southern Sudan: an opportunity for NTD control and elimination?
Q34997628Spatial heterogeneity of haemoglobin concentration in preschool-age children in sub-Saharan Africa
Q33328716Strongyloides stercoralis: a field-based survey of mothers and their preschool children using ELISA, Baermann and Koga plate methods reveals low endemicity in western Uganda.
Q58862731Surveillance of intestinal schistosomiasis during control: a comparison of four diagnostic tests across five Ugandan primary schools in the Lake Albert region
Q30645103The Lake Victoria Island Intervention Study on Worms and Allergy-related diseases (LaVIISWA): study protocol for a randomised controlled trial
Q39002257The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002-2008.
Q34496260The effect of a health communication campaign on compliance with mass drug administration for schistosomiasis control in western Kenya--the SCORE project
Q33637297The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial
Q33437988The epidemiology and control of urinary schistosomiasis and soil-transmitted helminthiasis in schoolchildren on Unguja Island, Zanzibar
Q37278516The impact of an 8-year mass drug administration programme on prevalence, intensity and co-infections of soil-transmitted helminthiases in Burundi
Q34245720The role of nutrition in integrated programs to control neglected tropical diseases
Q39196853Towards nationwide control of schistosomiasis in Yemen: a pilot project to expand treatment to the whole community
Q37113146Two-year impact of single praziquantel treatment on infection in the national control programme on schistosomiasis in Burkina Faso
Q35793397Understanding Heterogeneity in the Impact of National Neglected Tropical Disease Control Programmes: Evidence from School-Based Deworming in Kenya
Q38871350Understanding ethnic differences in behaviour relating to Schistosoma mansoni re-infection after mass treatment
Q28487697Uptake of preventive treatment for intestinal schistosomiasis among school children in Jinja district, Uganda: a cross sectional study
Q37655256Using the hierarchical ordinal regression model to analyse the intensity of urinary schistosomiasis infection in school children in Lusaka Province, Zambia
Q28477145Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: a systematic review

Search more.